Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1997-7-14
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/9186349-9186345,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9186349-9186346,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9186349-9186347,
http://linkedlifedata.com/resource/pubmed/commentcorrection/9186349-9186348
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-5347
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
158
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
178
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading | |
pubmed:year |
1997
|
pubmed:articleTitle |
Androgen ablation therapy--where to next?
|
pubmed:publicationType |
Editorial,
Comment
|